Skip to main content

RHUMBLINE ADVISERS

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1115418 BOSTON, MA

Position in RDY

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$3,209,502
-$572,551 QoQ
Shares Held
231,733
-14.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 30% Shared 0% None 70%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. RDY ranks #16 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RDY

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,209,502 231,733
2025-12-31 $3,782,053 269,377
2025-09-30 $3,885,517 277,934
2025-06-30 $5,528,018 367,799
2025-03-31 $4,527,981 343,289
2024-12-31 $6,790,678 430,062
2024-09-30 $6,123,052 77,068
2024-06-30 $5,763,240 75,643
2024-03-31 $6,926,073 94,425
2023-12-31 $6,659,293 95,707
2023-09-30 $5,977,041 89,383
2023-06-30 $5,613,382 88,946